Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review
Summary: Background: People who inject drugs (PWID) are a key population affected by the global HIV and hepatitis C virus (HCV) epidemics. HIV and HCV prevention interventions for PWID include needle and syringe programmes (NSP), opioid substitution therapy (OST), HIV counselling and testing, HIV a...
Main Authors: | Sarah Larney, DrPhD, Amy Peacock, PhD, Janni Leung, PhD, Samantha Colledge, BPSc, Matthew Hickman, ProfPhD, Peter Vickerman, ProfPhD, Jason Grebely, PhD, Kostyantyn V Dumchev, MD, Paul Griffiths, MSc, Lindsey Hines, PhD, Evan B Cunningham, BSc, Richard P Mattick, ProfPhD, Michael Lynskey, ProfPhD, John Marsden, ProfPhD, John Strang, Prof SirFMedSci, Louisa Degenhardt, ProfPhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-12-01
|
Series: | The Lancet Global Health |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214109X1730373X |
Similar Items
-
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review
by: Louisa Degenhardt, ProfPhD, et al.
Published: (2017-12-01) -
Artificial intelligence in COVID-19 drug repurposing
by: Yadi Zhou, PhD, et al.
Published: (2020-12-01) -
Integrating solutions to adapt cities for climate change
by: Brenda B Lin, PhD, et al.
Published: (2021-07-01) -
Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data
by: Dongshan Zhu, MD, et al.
Published: (2019-11-01) -
Paternal occupational exposure to chemicals and secondary sex ratio: results from the Japan Environment and Children's Study
by: Sho Adachi, PhD, et al.
Published: (2019-12-01)